S Mark Shearman

Evp, Chief Scientific Officer at Editas Medicine Inc. (EDIT), 2023-02-15
Chief Scientific Officer at Applied Genetic Technologies Corp (AGTC), 2020-08-18

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
AGTC	$8.87	1,300	$11,531.00	3,000	2016-09-22	Filing
AGTC	$8.87	1,700	$15,070.50	1,700	2016-09-22	Filing

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
EDIT	$9.67	2,790	$26,966.19	65,559	2023-02-13	Filing
EDIT	$10.06	5,145	$51,744.81	68,349	2022-06-15	Filing
AGTC	$3.35	3,000	$10,052.70	0	2018-12-14	Filing